Japanese universal health care faces a crisis in cancer treatment

Lancet Oncol. 2015 Mar;16(3):251-2. doi: 10.1016/S1470-2045(15)70007-0.

¹ Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Strategic Planning Bureau, National Cancer Center, Tokyo, Japan; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: yfujiwar@ncc.go.jp.
² Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
³ Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Strategic Planning Bureau, National Cancer Center, Tokyo, Japan; Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan.
⁴ Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
⁵ Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Strategic Planning Bureau, National Cancer Center, Tokyo, Japan.

No abstract available

MeSH terms